GlaxoSmithKline (GSK)

44.28 +0.04  +0.09%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

GlaxoSmithKline Capital Expenditures: 248.21M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

GSK Capital Expenditures Rankings

Overall 5th percentile 4225 of 4450
Sector 0th percentile 503 of 507 in Healthcare
Industry 12th percentile 22 of 25 in Drug Manufacturers - Major

GSK Capital Expenditures Range, Past 5 Years

Minimum 0.00 Mar 2008
Maximum 1.165B Jun 2008
Average 522.26M

About Capex

Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).

Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.

Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.

Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More

You may also be interested in these GSK related companies

Display in Live Stream: Done
Options

GSK News

4 Stocks Buffett May Be Buying in Europe
May 25, 12:21PM Investor Place
Finding a Pathway to Approval
May 24, 2:53PM Fool
$GSK reacts to $HGSI poison pill. Stubborn, or what? It seems they do not want to get pushed or pulled.
about 3 days ago by OysterX
20 Giants for a 6% Dividend Yield
May 21, 9:07AM Fool
@xjun &quot;totally betrayed&quot; $AMRN says: &quot;Sorry, it&#39;s not personal. Look at some of my neighbours: $ONTY, $SPPI, $NVAX, $GSK, $TEVA, $CELG ...&quot;
about 8 days ago by mitrado
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
Still think that $GSK will not succeed with $HGSI takeover at 13/share. They will increase the offer price, but probably not above 15.
about 9 days ago by OysterX
News related to $GSK, currently 0.0% since open: &#39;Prestige Brands posts small fiscal 4Q loss&#39; http://stks.co/3s9V
about 9 days ago by TradeBot
Gilead Sciences’ HIV Drugs Clear a Hurdle
May 17, 10:00AM Investor Place
$GSK Trametinib also in the spotlight at ASCO &#39;12 with six presentations over 4 days. http://stks.co/3roL
about 9 days ago by abubnic
$GSK Dabrafenib getting its share of attention at ASCO &#39;12 with 50 presentations over 4 days. http://stks.co/3roI
about 9 days ago by abubnic
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 11 days ago by laughing_stock
Don&#39;t see $XNPT popping 100% like $ARNA did, not as glamorous and still has to settle with $GSK. They would get 10 million if still partnrd
about 11 days ago by Glopolon
5 Dividends to Reinvest
May 14, 10:34AM Fool
$ARNA -Big brand name companies may be interested in buyout $GSK $PFE $SNY $ABT First weight-loss drug in US may be approved in June $SPY $$
about 13 days ago by peterumble
$XNPT, No Debt, Drug has already been approved for RLS, so safety issues known. Court case with $GSK still out there, want settlement.
about 15 days ago by Glopolon
Some really tempting European stocks that pay healthy dividends $SNY $HBC $SI $ABB $SNY $GSK $RDS.B all above 4%
about 17 days ago by sld1986
$VVUS Racked With Losses, Vivus is Putting All Its Eggs in This Basket http://stks.co/3kNz $OREX $ARNA $PFE $LLY $GSK
about 17 days ago by DrNick
RT @JasonMilano8 $AMRN Here is a news about current CEO of Amarin selling his former company Reliant to ($GSK) in 2007: http://stks.co/3k0G
about 17 days ago by JasonMilano8
Breakfast Links | via @PointsnFigures http://stks.co/3jto $AMZN $GSK $HGSI $ZNGA
about 17 days ago by STNet
That&#39;s a surprise. $GSK goes hostile with $HGSI offer at 13. Did not expect that and am curious whether HGSI has something up its sleeve.
about 17 days ago by OysterX
$AMRN Here is a news about current CEO of Amarin selling his former company Reliant to GlaxoSmithKline ($GSK) in 2007: http://stks.co/3jYt
about 17 days ago by JasonMilano8
$XNPT, Only non-dopaminergic option for RLS, is the advantage over generics. If $XNPT can work things out with $GSK, this should be $5+
about 18 days ago by Glopolon
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 18 days ago by abubnic
@BioRunUp @GantosJ $XNPT, Hope that they can settle w/ $GSK, and if Astellas in Japan is competent, then $XNPT is looking good.
about 19 days ago by Glopolon
$XNPT Sounds like Astellas is going to be better partner than $GSK, Hope they can work things out with $GSK re: Horizant.
about 20 days ago by Glopolon
$XNPT $GSK, FDA PDUFA date June 9th for Horizant treating postherpetic neuralgia. Horizant already approved in Japan for restless leg synd.
about 22 days ago by Glopolon
Biotech targets fight back as Big Pharma circles. $GSK $BMY $PFE $HGSI $AMLN $ONXX $ILMN $AZN http://stks.co/3dnZ
about 23 days ago by abubnic
Best Yielding Large Cap Healthcare Stocks + http://stks.co/3cMJ + $JNJ $PFE $NVS $MRK $GSK $SNY $NVO $UNH $BMY $TEVA $MDT $BAX $AGN $SYK
about 24 days ago by DividendYield
@WolfpackInvest I never hold long through PDUFA but I&#39;m making an exception for $AMRN. Dont sell your position unles $PHE or $GSK are buying
about 25 days ago by junkmailman
$AMRN i still think GlaxoSmithKline ($GSK) will grab Amarin $AMRN around $20. We should see $AMRN here soon: http://stks.co/3aOF
about 26 days ago by JasonMilano8
$AMRN price target upgraded to 20$ by Citi $C , already $JPM has upgraded to 25$, buyout candidate $GSK $NVS $AZN $$
about 26 days ago by peterumble
Emerging market push and Genzyme acquisition paying dividends for $SNY 9.9% sales growth significantly outperforming rivals $GSK and $AZN
about 29 days ago by sld1986
FDA Approves $GSK Cancer Drug Votrient For Soft-Tissue Sarcoma. http://stks.co/3YAc
about 29 days ago by abubnic
$GSK FDA stamps approval on GSK cancer drug Votrient. http://stks.co/3YAV Subscribe: http://stks.co/3YAW
about 29 days ago by abubnic
News related to $GSK: &#39;Human Genome Sciences takes smaller 1Q loss&#39; http://stks.co/3VqK
about 31 days ago by TradeBot

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 44.28 +0.04 +0.09% 111.75B
GSIT 4.20 +0.00 +0.00% 120.25M
GSB 2.15 +0.03 +1.42% 39.15M
GSAT 0.4049 +0.03 +6.58% 120.61M
GS 96.70 -0.16 -0.17% 47.86B
GRZ 3.29 +0.07 +2.17% 195.89M
GRRF 3.11 +0.00 +0.00% 70.69M
GRO 1.07 +0.00 +0.00% 59.26M
GRMN 43.19 -0.53 -1.21% 8.406B
GRA 52.56 -1.03 -1.92% 3.886B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close